Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Stroke|August 30, 2008
Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysisDavid M Greer, Susan E Funk, Nancy L Reaven, et al.
Archives of Biochemistry and Biophysics|January 1, 1996
Expression of biologically active human SPARC in Escherichia coliJ A Bassuk, F Baneyx, R B Vernon, et al.
Aging Cell|November 17, 2024
Compromised CD8+ T cell immunity in the aged brain increases severity of neurotropic coronavirus infection and postinfectious cognitive impairmentKatie L Reagin, Rae-Ling Lee, Luke A Williams, et al.
Journal of Water and Health|September 24, 2004
The potential for health risks from intrusion of contaminants into the distribution system from pressure transientsMark W LeChevallier, Richard W Gullick, Mohammad R Karim, et al.
The American Journal of Cardiology|January 27, 2009
Frequency of electrocardiographic recordings in patients presenting with angina pectoris (from the Investigation of National Coronary Disease Identification)James Li, Nancy L Reaven, Susan E Funk, et al.
Leukemia|July 13, 2007
Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null miceS Lehmann, J O'Kelly, S Raynaud, et al.
Journal of Cellular Biochemistry|February 9, 2002
Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitorsKouros Motamed, Sarah E Funk, Hidenori Koyama, et al.
Kidney International Reports|April 18, 2023
Increasing Serum Bicarbonate is Associated With Reduced Risk of Adverse Kidney Outcomes in Patients with CKD and Metabolic AcidosisNavdeep Tangri, Thomas W Ferguson, Nancy L Reaven, et al.
Proteomics Insights|March 12, 2019
Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human CellsJiang Zhang, Guangli Wang, Wei-Wu He, et al.
The American Journal of Managed Care|December 1, 2015
Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitorsMurray Epstein, Nancy L Reaven, Susan E Funk, et al.
Pageof 16